Smart. Sharp. Funny. Fearless.
Sunday, March 24, 2019

Sealed Evidence: Sackler Schemed to Hide OxyContin Strength From Doctors

In May 1997, the year after Purdue Pharma launched OxyContin, its head of sales and marketing sought input on a key decision from Dr. Richard Sackler, a member of the billionaire family that founded and controls the company. Michael Friedman told Sackler that he didn’t want to correct the false impression among doctors that OxyContin was weaker than morphine, because the myth was boosting prescriptions — and sales.

“It would be extremely dangerous at this early stage in the life of the product,” Friedman wrote to Sackler, “to make physicians think the drug is stronger or equal to morphine….We are well aware of the view held by many physicians that oxycodone [the active ingredient in OxyContin] is weaker than morphine.



Read More

On Drug Prices, Americans Are The Real Suckers

Reprinted with permission from Creators.

 

Drugmakers rang in the new year by raising prices on hundreds of products — American prices, that is. Americans focused on the celebrations weren’t paying attention.

Allergan led the parade, hiking its prices by 10 percent on more than two dozen drugs. But note this: It didn’t raise the price of Botox, the anti-wrinkle treatment. Why? Because most users of Botox pay for it out of pocket. They can say, “I’m not bearing the extra freight. I think I’ll go another few months with crow’s-feet.”

Markets in which buyers and sellers haggle can bring reason to prices.…

Read More